Consolidated Portfolio Review Corp »

Gilead Sciences shares owned by Consolidated Portfolio Review Corp

Quarter-by-quarter ownership of Gilead Sciences (GILD) shares owned by Consolidated Portfolio Review Corp from 13F filings

Historical chart of Consolidated Portfolio Review Corp investment in Gilead Sciences

Tip: Access up to 7 years of quarterly data

All positions including Gilead Sciences held by Consolidated Portfolio Review Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gilead Sciences by Consolidated Portfolio Review Corp

Quarter filed Position value Share count Share price at filing
2025-09-30 $294k 2.6k 111.01

More positions owned by Consolidated Portfolio Review Corp

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Value Etf (VTV)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Strategy Cl A New (MSTR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
NVIDIA Corporation (NVDA)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Amazon (AMZN)
Vanguard World Health Car Etf (VHT)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)

View all positions for Consolidated Portfolio Review Corp

Top funds holding Gilead Sciences

Vanguard Group
BlackRock
FMR
State Street Corporation
Capital World Investors
Dodge & Cox
Capital Research Global Investors
Geode Capital Management
Wellington Management Company
Morgan Stanley
Jpmorgan Chase & Co
Invesco
Northern Trust
Bank of New York Mellon
Ubs Global Asset Management Americas

View all funds holding Gilead Sciences